Resveratrol increases nitric oxide synthase, induces accumulation of p53 and p21(WAF1/CIP1), and suppresses cultured bovine pulmonary artery endothelial cell proliferation by perturbing progression through S and G2.

PubWeight™: 1.20‹?› | Rank: Top 10%

🔗 View Article (PMID 10363980)

Published in Cancer Res on June 01, 1999

Authors

T C Hsieh1, G Juan, Z Darzynkiewicz, J M Wu

Author Affiliations

1: Department of Biochemistry and Molecular Biology, New York Medical College, Valhalla 10595, USA.

Articles citing this

Molecular mechanism of endothelial growth arrest by laminar shear stress. Proc Natl Acad Sci U S A (2000) 1.83

Resveratrol: French paradox revisited. Front Pharmacol (2012) 1.40

Cell cycle control as a basis for cancer chemoprevention through dietary agents. Front Biosci (2008) 1.31

Association between pterostilbene and quercetin inhibits metastatic activity of B16 melanoma. Neoplasia (2005) 1.25

Resveratrol induces p53-independent, X-linked inhibitor of apoptosis protein (XIAP)-mediated Bax protein oligomerization on mitochondria to initiate cytochrome c release and caspase activation. J Biol Chem (2011) 1.14

Nutritional improvement of the endothelial control of vascular tone by polyphenols: role of NO and EDHF. Pflugers Arch (2010) 1.10

Resveratrol-induced gene expression profiles in human prostate cancer cells. Cancer Epidemiol Biomarkers Prev (2005) 1.05

Resveratrol and diabetic cardiac function: focus on recent in vitro and in vivo studies. J Bioenerg Biomembr (2012) 1.02

Resveratrol increases BRCA1 and BRCA2 mRNA expression in breast tumour cell lines. Br J Cancer (2003) 0.92

Metabolic engineering of yeast and plants for the production of the biologically active hydroxystilbene, resveratrol. J Biomed Biotechnol (2012) 0.92

Red wine polyphenols induce EDHF-mediated relaxations in porcine coronary arteries through the redox-sensitive activation of the PI3-kinase/Akt pathway. Br J Pharmacol (2004) 0.90

Significance of wine and resveratrol in cardiovascular disease: French paradox revisited. Exp Clin Cardiol (2006) 0.90

Induction of cell cycle changes and modulation of apoptogenic/anti-apoptotic and extracellular signaling regulatory protein expression by water extracts of I'm-Yunity (PSP). BMC Complement Altern Med (2006) 0.90

Role of Bax in resveratrol-induced apoptosis of colorectal carcinoma cells. BMC Cancer (2002) 0.90

Pro-angiogenic effects of resveratrol in brain endothelial cells: nitric oxide-mediated regulation of vascular endothelial growth factor and metalloproteinases. J Cereb Blood Flow Metab (2012) 0.89

Cardioprotection by resveratrol: a review of effects/targets in cultured cells and animal tissues. Am J Cardiovasc Dis (2011) 0.87

Engineering vascularized tissues using natural and synthetic small molecules. Organogenesis (2008) 0.86

Induced cytoskeletal changes in bovine pulmonary artery endothelial cells by resveratrol and the accompanying modified responses to arterial shear stress. BMC Cell Biol (2001) 0.86

Resveratrol induces apoptosis by directly targeting Ras-GTPase-activating protein SH3 domain-binding protein 1. Oncogene (2014) 0.85

Reduction of graphene oxide by resveratrol: a novel and simple biological method for the synthesis of an effective anticancer nanotherapeutic molecule. Int J Nanomedicine (2015) 0.85

Natural Polyphenols Inhibit Lysine-Specific Demethylase-1 in vitro. J Biochem Pharmacol Res (2013) 0.82

Anti-proliferative and gene expression actions of resveratrol in breast cancer cells in vitro. Oncotarget (2014) 0.82

Inhibition of sphingolipid metabolism enhances resveratrol chemotherapy in human gastric cancer cells. Biomol Ther (Seoul) (2012) 0.81

Inhibition of mammalian DNA polymerases by resveratrol: mechanism and structural determinants. Biochem J (2005) 0.79

Impact of trans-resveratrol-sulfates and -glucuronides on endothelial nitric oxide synthase activity, nitric oxide release and intracellular reactive oxygen species. Molecules (2014) 0.77

Characterization of the 5'-flanking region of the human TP53 gene and its response to the natural compound, Resveratrol. J Biochem (2015) 0.76

Age Impaired endothelium-dependent vasodilation is improved by resveratrol in rat mesenteric arteries. J Exerc Nutrition Biochem (2016) 0.75

Effects of resveratrol on ARPE-19 cell proliferation and migration via regulating the expression of proliferating cell nuclear antigen, P21, P27 and p38MAPK/MMP-9. Int J Ophthalmol (2016) 0.75

Natural Compounds as Modulators of Cell Cycle Arrest: Application for Anticancer Chemotherapies. Curr Genomics (2017) 0.75

A Novel Resveratrol Based Tubulin Inhibitor Induces Mitotic Arrest and Activates Apoptosis in Cancer Cells. Sci Rep (2016) 0.75

Effects of resveratrol on the insulin signaling pathway of obese mice. J Vet Sci (2014) 0.75

Schiff base derived from thiosemicarbazone and anthracene showed high potential in overcoming multidrug resistance in vitro with low drug resistance index. Drug Des Devel Ther (2017) 0.75

Articles by these authors

Endothelial apoptosis as the primary lesion initiating intestinal radiation damage in mice. Science (2001) 7.13

Detection of DNA strand breaks in individual apoptotic cells by the in situ terminal deoxynucleotidyl transferase and nick translation assays. Cancer Res (1993) 4.11

Cytometry in cell necrobiology: analysis of apoptosis and accidental cell death (necrosis). Cytometry (1997) 3.90

Simultaneous human granulocytic ehrlichiosis and Lyme borreliosis. N Engl J Med (1997) 2.69

Neuroblastic and Schwannian stromal cells of neuroblastoma are derived from a tumoral progenitor cell. Cancer Res (2001) 2.48

A selective procedure for DNA extraction from apoptotic cells applicable for gel electrophoresis and flow cytometry. Anal Biochem (1994) 2.41

Lymphocyte stimulation: a rapid multiparameter analysis. Proc Natl Acad Sci U S A (1976) 2.37

Simultaneous staining of ribonucleic and deoxyribonucleic acids in unfixed cells using acridine orange in a flow cytofluorometric system. J Histochem Cytochem (1977) 2.23

Human epidermal cell cultures: growth and differentiation in the absence of differentiation in the absence of dermal components or medium supplements. Proc Natl Acad Sci U S A (1979) 2.16

Histone H3 phosphorylation and expression of cyclins A and B1 measured in individual cells during their progression through G2 and mitosis. Cytometry (1998) 2.11

New cell cycle compartments identified by multiparameter flow cytometry. Cytometry (1980) 2.03

Relationship between RNA content and progression of lymphocytes through S phase of cell cycle. Proc Natl Acad Sci U S A (1979) 1.94

The cell cycle related differences in susceptibility of HL-60 cells to apoptosis induced by various antitumor agents. Cancer Res (1993) 1.88

Activation-induced expression of human programmed death-1 gene in T-lymphocytes. Exp Cell Res (1997) 1.85

Subcompartments of the G1 phase of cell cycle detected by flow cytometry. Proc Natl Acad Sci U S A (1980) 1.76

Molecular cloning of the bombesin/gastrin-releasing peptide receptor from Swiss 3T3 cells. Proc Natl Acad Sci U S A (1991) 1.75

Constitutive expression of p53 protein in enriched normal human marrow blast cell populations. Blood (1992) 1.69

Segregation of RNA and separate packaging of DNA and RNA in apoptotic bodies during apoptosis. Exp Cell Res (2000) 1.67

Conformation of RNA in situ as studied by acridine orange staining and automated cytofluorometry. Exp Cell Res (1975) 1.66

Activation of caspases measured in situ by binding of fluorochrome-labeled inhibitors of caspases (FLICA): correlation with DNA fragmentation. Exp Cell Res (2000) 1.64

Accessibility of DNA in situ to various fluorochromes: relationship to chromatin changes during erythroid differentiation of Friend leukemia cells. Cytometry (1984) 1.60

Cell cycle dependent expression and stability of the nuclear protein detected by Ki-67 antibody in HL-60 cells. Cell Prolif (1992) 1.58

Thermal denaturation of DNA in situ as studied by acridine orange staining and automated cytofluorometry. Exp Cell Res (1975) 1.55

Differential effects on growth, cell cycle arrest, and induction of apoptosis by resveratrol in human prostate cancer cell lines. Exp Cell Res (1999) 1.54

Cell cycle-specific effects of lovastatin. Proc Natl Acad Sci U S A (1991) 1.54

Cell cycle-related changes in nuclear chromatin of stimulated lymphocytes as measured by flow cytometry. Cancer Res (1977) 1.53

Down-regulation of a serine protease, myeloblastin, causes growth arrest and differentiation of promyelocytic leukemia cells. Cell (1989) 1.52

Induction of DNA strand breaks associated with apoptosis during treatment of leukemias. Leukemia (1993) 1.50

Relation of mammalian sperm chromatin heterogeneity to fertility. Science (1980) 1.49

Labelling DNA strand breaks with BrdUTP. Detection of apoptosis and cell proliferation. Cell Prolif (1995) 1.48

Increased mitochondrial uptake of rhodamine 123 during lymphocyte stimulation. Proc Natl Acad Sci U S A (1981) 1.47

Flow cytometric detection of apoptosis: comparison of the assays of in situ DNA degradation and chromatin changes. Cytometry (1994) 1.45

Interactions of acridine orange with double stranded nucleic acids. Spectral and affinity studies. J Biomol Struct Dyn (1987) 1.44

Growth imbalance and altered expression of cyclins B1, A, E, and D3 in MOLT-4 cells synchronized in the cell cycle by inhibitors of DNA replication. Cell Growth Differ (1995) 1.41

Cytometry of cyclin proteins. Cytometry (1996) 1.40

Flow cytofluorimetry: discrimination between single cells and cell aggregates by direct size measurements. Acta Cytol (1976) 1.38

Flow-cytometric enumeration of reticulocytes with the new fluorochrome 1,3'-diethyl-4,2'-quinolylthiacyanine (correction of 1',3'-diethyl-4,2'-quinolylthiacyanine) Ann Hematol (1992) 1.38

Interactions of fluorochrome-labeled caspase inhibitors with apoptotic cells: a caution in data interpretation. Cytometry A (2003) 1.37

Activation of nuclear factor kappa B (NF-kappaB) assayed by laser scanning cytometry (LSC). Cytometry (1998) 1.36

Constitutive histone H2AX phosphorylation and ATM activation are strongly amplified during mitogenic stimulation of lymphocytes. Cell Prolif (2007) 1.33

Correlation between cell cycle duration and RNA content. J Cell Physiol (1979) 1.33

Induction of H2AX phosphorylation in pulmonary cells by tobacco smoke: a new assay for carcinogens. Cell Cycle (2004) 1.33

Interaction of rhodamine 123 with living cells studied by flow cytometry. Cancer Res (1982) 1.32

Discrimination of human leukemia subtypes by flow cytometric analysis of cellular DNA and RNA. Blood (1980) 1.29

Analysis of apoptosis by laser scanning cytometry. Cytometry (1999) 1.29

Cell cycle-specific effects of tumor necrosis factor. Cancer Res (1984) 1.28

Flow cytometry of breast carcinoma: I. Relation of DNA ploidy level to histology and estrogen receptor. Cancer (1981) 1.28

Effect of carbon dioxide on diaphragmatic function in human beings. N Engl J Med (1984) 1.28

Flow cytometry of colorectal carcinoma with three-year follow-up. Dis Colon Rectum (1986) 1.28

Detection of caspases activation by fluorochrome-labeled inhibitors: Multiparameter analysis by laser scanning cytometry. Cytometry (2001) 1.27

Single-step procedure for labeling DNA strand breaks with fluorescein- or BODIPY-conjugated deoxynucleotides: detection of apoptosis and bromodeoxyuridine incorporation. Cytometry (1995) 1.27

Overexpression of DR-nm23, a protein encoded by a member of the nm23 gene family, inhibits granulocyte differentiation and induces apoptosis in 32Dc13 myeloid cells. Proc Natl Acad Sci U S A (1995) 1.26

Presence of DNA strand breaks and increased sensitivity of DNA in situ to denaturation in abnormal human sperm cells: analogy to apoptosis of somatic cells. Exp Cell Res (1993) 1.26

Quantitative studies on enzymes in structures in striated muscles by labeled inhibitor methods. I. The number of acetylcholinesterase molecules and of other DFP-reactive sites at motor endplates, measured by radioautography. J Cell Biol (1969) 1.24

Lysosomal proton pump activity: supravital cell staining with acridine orange differentiates leukocyte subpopulations. Methods Cell Biol (1994) 1.24

Magnetic resonance imaging of the pharynx in OSA patients and healthy subjects. Eur Respir J (2001) 1.23

Two-chain high molecular weight kininogen induces endothelial cell apoptosis and inhibits angiogenesis: partial activity within domain 5. FASEB J (2000) 1.23

Telomere shortening is an in vivo marker of myocyte replication and aging. Am J Pathol (2000) 1.21

Unscheduled expression of cyclin B1 and cyclin E in several leukemic and solid tumor cell lines. Cancer Res (1994) 1.20

Relationship between the pharmacological activity of antitumor drugs Ametantrone and mitoxantrone (Novatrone) and their ability to condense nucleic acids. Proc Natl Acad Sci U S A (1986) 1.20

The S-phase cytotoxicity of camptothecin. Exp Cell Res (1991) 1.20

G1 arrest of U937 cells by onconase is associated with suppression of cyclin D3 expression, induction of p16INK4A, p21WAF1/CIP1 and p27KIP and decreased pRb phosphorylation. Leukemia (1998) 1.19

ATM activation and histone H2AX phosphorylation as indicators of DNA damage by DNA topoisomerase I inhibitor topotecan and during apoptosis. Cell Prolif (2006) 1.19

Clinical and laboratory spectrum of culture-proven human granulocytic ehrlichiosis: comparison with culture-negative cases. Clin Infect Dis (1998) 1.19

Cantrell's syndrome in an infant. J Formos Med Assoc (1997) 1.19

Correlated measurements of DNA, RNA, and protein in individual cells by flow cytometry. Science (1985) 1.18

Myocyte cellular hyperplasia and myocyte cellular hypertrophy contribute to chronic ventricular remodeling in coronary artery narrowing-induced cardiomyopathy in rats. Circ Res (1994) 1.17

Apoptosis in adult retinal ganglion cells after axotomy. J Neurobiol (1994) 1.15

Changes in deoxyribonucleoprotein during spermiogenesis in the bull. Sensitivity of DNA to heat denaturation. Exp Cell Res (1970) 1.15

DNA strand breaks occurring during apoptosis - their early insitu detection by the terminal deoxynucleotidyl transferase and nick translation assays and prevention by serine protease inhibitors. Int J Oncol (1992) 1.15

Cell heterogeneity during the cell cycle. J Cell Physiol (1982) 1.15

Caffeine modulates the effects of DNA-intercalating drugs in vitro: a flow cytometric and spectrophotometric analysis of caffeine interaction with novantrone, doxorubicin, ellipticine, and the doxorubicin analogue AD198. Cancer Res (1991) 1.13

Double-lumen aortic arch with anomalous left pulmonary artery origin from the main pulmonary artery--bilateral persistent fifth aortic arch--a case report. Int J Cardiol (1999) 1.13

Detection of apoptosis and DNA replication by differential labeling of DNA strand breaks with fluorochromes of different color. Exp Cell Res (1996) 1.12

Human kappa opiate receptor second extracellular loop elevates dynorphin's affinity for human mu/kappa chimeras. J Biol Chem (1994) 1.12

BubR1 is involved in regulation of DNA damage responses. Oncogene (2006) 1.11

Immunoseparation and immunodetection of nucleic acids labeled with halogenated nucleotides. Exp Cell Res (1997) 1.11

Telomerase expression and activity are coupled with myocyte proliferation and preservation of telomeric length in the failing heart. Proc Natl Acad Sci U S A (2001) 1.10

Aging of the liver: age-associated mitochondrial damage in intact hepatocytes. Hepatology (1996) 1.10

Changes in accessibility of DNA to various fluorochromes during spermatogenesis. Cytometry (1986) 1.10

Identification of a delta isoform of preprotachykinin mRNA in human mononuclear phagocytes and lymphocytes. J Neuroimmunol (1998) 1.10

Regulation of G1/S transition and induction of apoptosis in HL-60 leukemia cells by fenretinide (4HPR). Int J Cancer (1998) 1.09

Inhibiting Ras prenylation increases the radiosensitivity of human tumor cell lines with activating mutations of ras oncogenes. Cancer Res (1998) 1.09

Novel antitumor artemisinin derivatives targeting G1 phase of the cell cycle. Bioorg Med Chem Lett (2001) 1.08

Changes in deoxyribonucleo-protein during spermiogenesis in the bull. 3 H-Actinomycin D binding capacity. Exp Cell Res (1969) 1.08

Onconase and amphinase, the antitumor ribonucleases from Rana pipiens oocytes. Curr Pharm Biotechnol (2008) 1.07

Interactions of antitumor agents Ametantrone and Mitoxantrone (Novatrone) with double-stranded DNA. Biochem Pharmacol (1985) 1.06

Chromatin condensation and sensitivity of DNA in situ to denaturation during cell cycle and apoptosis--a confocal microscopy study. Micron (2001) 1.06

A comparison of cell cycle-related changes in postmitotic and quiescent AF8 cells as measured by cytofluorometry after acridine orange staining. Cancer Res (1978) 1.05

Synchronization in the cell cycle by inhibitors of DNA replication induces histone H2AX phosphorylation: an indication of DNA damage. Cell Prolif (2006) 1.05

Interactions of a new antitumor agent, 1,4-dihydroxy-5,8-bis[[2-[(2-hydroxyethyl)amino]-ethyl]amino]-9,10-anthracenedione, with nucleic acids. Biochem Pharmacol (1981) 1.04

Cleavage of Poly(ADP-ribose) polymerase measured in situ in individual cells: relationship to DNA fragmentation and cell cycle position during apoptosis. Exp Cell Res (2000) 1.03

Actinomycin binding of normal and phytohaemagglutinin stimulated lymphocytes. Exp Cell Res (1969) 1.03

Relationship between DNA damage response, initiated by camptothecin or oxidative stress, and DNA replication, analyzed by quantitative 3D image analysis. Cytometry A (2013) 1.03

Flow cytometry of breast carcinoma: II. Relation of tumor cell cycle distribution to histology and estrogen receptor. Cancer (1981) 1.02

HEPES-buffered media in lymphocyte cultures. Proc Soc Exp Biol Med (1971) 1.02

Failure of accumulation of cellular RNA in hamster cells stimulated to synthesize DNA by infection with adenovirus 2. J Biol Chem (1980) 1.02